CVE-2024-22153: Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Fahad Ma
CVE-2024-22153 is a medium-severity flaw (CVSS 5.9) affecting stock locations for woocommerce. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Fahad Mahmood & Alexandre Faustino Stock Locations for WooCommerce allows Stored XSS.This issue affects Stock Locations for WooCommerce: from n/a through 2.5.9.
Why this priority
- No elevated risk signals yet
A fixed release or distro patch exists.
Risk facts
| CVSS score | 5.9 (Medium) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | High |
| User interaction | Required |
| EPSS exploit chance | 0.4% (top 70%) |
| CISA exploited list | No |
| Weakness | CWE-79 |
| Published | 2024-01-31 |
| Last modified | 2026-06-17 |
Last updated 2026-06-17 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2024-22153?
stock locations for woocommerce: upgrade to 2.6.0. Exact commands for each OS are on this page.
Is CVE-2024-22153 being exploited?
CVE-2024-22153 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2024-22153 affect?
CVE-2024-22153 affects stock locations for woocommerce. Severity is medium (CVSS 5.9). Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Fahad Mahmood & Alexandre Faustino Stock Locations for WooCommerce allows Stored XSS.This issue affects Stock Locations for WooCommerce: f
How urgent is CVE-2024-22153?
Priority 28/100. No elevated risk signals yet.